We downloaded gene expression data and related clinical information data from the TCGA-LIHC database for patients with HCC and discovered that SKA1 was substantially differentially expressed in malignant tumors (P < .001; Fig. 2C and D). The gene discussed is SKA1; the disease is cancer.